Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study
about
Risk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple SclerosisAccess and barriers to MS care in Latin America.Aggressive multiple sclerosis: proposed definition and treatment algorithm.The current role of mitoxantrone in the treatment of multiple sclerosis.Therapy-related acute leukaemia with mitoxantrone: four years on, what is the risk and can it be limited?Teriflunomide for the treatment of relapsing-remitting multiple sclerosis.Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from Qatar.Efficacy and safety of mitoxantrone use in primary and secondary progressive multiple sclerosis - study site experience based on the therapy of 104 patients.Cardiotoxicity of mitoxantrone treatment in a german cohort of 639 multiple sclerosis patients.Drugs approved for the treatment of multiple sclerosis: review of their safety profile.
P2860
Q28087414-6D05505F-79CA-4F42-A7B6-E89C44D315A6Q33692243-C5051FFC-157B-437D-85A0-A61AA2A79036Q34478828-61F5EF50-76F2-4D7D-B20E-EA267D86A3DEQ38212259-C249166D-4BCB-43C3-9DF4-E6F4B314294FQ38228300-076BB35F-1ADA-44C2-80C9-F479CEC41A13Q38289353-0663BD77-96A3-4E8D-8CF0-88017A4DC07CQ39021942-BDE82A74-2E1E-45BE-97E1-98618248AF4FQ40423250-A4AAACAE-A129-40FB-B77B-C2AA456A2BE2Q41998267-BAB88844-10C8-4AEA-AD4D-4A33BCDA583DQ47868767-3CB490DD-1778-4366-A67E-F805E80EFD9A
P2860
Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Results from the 5-year, phase ...... ning Multiple Sclerosis) study
@ast
Results from the 5-year, phase ...... ning Multiple Sclerosis) study
@en
Results from the 5-year, phase ...... ning Multiple Sclerosis) study
@nl
type
label
Results from the 5-year, phase ...... ning Multiple Sclerosis) study
@ast
Results from the 5-year, phase ...... ning Multiple Sclerosis) study
@en
Results from the 5-year, phase ...... ning Multiple Sclerosis) study
@nl
prefLabel
Results from the 5-year, phase ...... ning Multiple Sclerosis) study
@ast
Results from the 5-year, phase ...... ning Multiple Sclerosis) study
@en
Results from the 5-year, phase ...... ning Multiple Sclerosis) study
@nl
P2093
P2860
P356
P1433
P1476
Results from the 5-year, phase ...... ning Multiple Sclerosis) study
@en
P2093
Daena Bock
Douglas R Jeffery
Fernando Dangond
Victor M Rivera
P2860
P2888
P356
10.1186/1471-2377-13-80
P577
2013-07-11T00:00:00Z
P5875
P6179
1046728076